Section Arrow
RLAY.NASDAQ
- Relay Therapeutics
Quotes are at least 15-min delayed:2026/02/23 14:33 EST
Regular Hours
Last
 8.87
+0.17 (+1.95%)
Day High 
9.005 
Prev. Close
8.7 
1-M High
9.54 
Volume 
431.79K 
Bid
8.85
Ask
8.87
Day Low
8.645 
Open
8.66 
1-M Low
7.36 
Market Cap 
1.51B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 8.93 
20-SMA 8.46 
50-SMA 8.22 
52-W High 9.54 
52-W Low 1.775 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.72/-1.83
Enterprise Value
1.55B
Balance Sheet
Book Value Per Share
3.51
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
10.01M
Operating Revenue Per Share
0.15
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
GOSSGossamer Bio0.379-1.751-82.21%-- 
IBRXImmunityBio9.7745+1.0745+12.35%-- 
VNDAVanda Pharmaceuticals8.36+2.6+45.14%-- 
IKTInhibikase Therapeutics1.87+0.11+6.25%3.74PE
ACLXArcellx113.785+49.675+77.48%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.